A carregar...

5α-ReductaseType 3 Enzyme in Benign and Malignant Prostate

BACKGROUND: Currently available 5α-reductase inhibitors are not completely effective for treatment of benign prostate enlargement, prevention of prostate cancer (CaP), or treatment of advanced castration-recurrent (CR) CaP. We tested the hypothesis that a novel 5α-reductase, 5α-reductase-3, contribu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Titus, Mark A., Li, Yun, Kozyreva, Olga G., Maher, Varun, Godoy, Alejandro, Smith, Gary J., Mohler, James L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3992828/
https://ncbi.nlm.nih.gov/pubmed/24150795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!